FDA recall D-1302-2020

QuVa Pharma, Inc. · Class II · drug

Product

oxyTOCIN 30 Units/500 mL (0.06 Units/mL) added to 0.9% Sodium Chloride Injection for IV Use, Rx only, QuVa Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 888-339-0874, NDC 70092-1068-07

Reason for recall

Subpotent drug - Product did not contain drug.

Distribution

USA Nationwide

Key facts

Status: Terminated
Initiation date: 2020-05-28
Report date: 2020-06-17
Termination date: 2022-01-19
Voluntary/Mandated: Voluntary: Firm initiated
Location: Sugar Land, TX, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1302-2020